Australian Statistics on Medicines 2010

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
ALKYLATING AGENTS
NITROGEN MUSTARD ANALOGUES

L01AA02

CHLORAMBUCIL

P

1163F

Tablet 2mg

—

—

3,546

429,550

L01AA01

CYCLOPHOSPHAMIDE

P

1031G

Injection 2g (solvent required)

—

—

11,708

631,658

P

1079T

Injection 500mg (solvent required)

—

—

3,599

133,945

P

1080W

Injection 1g (solvent required)

—

—

5,626

187,203

P

1266P

Tablet 50mg

—

—

9,362

282,409

P

5914G

Injection 500mg (solvent required)

—

—

3,450

51,419

P

5915H

Injection 1g (solvent required)

—

—

5,589

112,853

P

5916J

Injection 2g (solvent required)

—

—

1,897

77,146

P

6704W

Injection 500 mg 10mL and NS

—

—

922

44,417

P

6710E

Injection 1g 10mL and NS

—

—

1,830

69,731

P

7055H

Injection 2g 10mL and NS

—

—

991

62,002

L01AA06

IFOSFAMIDE

P

5943T

Powder for I.V. injection 1g

—

—

435

79,623

P

5944W

Powder for I.V. injection 2g

—

—

219

78,345

P

8076C

Powder for I.V. injection 1g

—

—

345

112,447

P

8077D

Powder for I.V. injection 2g

—

—

1,022

628,368

L01AA03

MELPHALAN

P

2547C

Tablet 2mg

—

—

3,078

150,417

ALKYL SULPHONATES

L01AB01

BUSULPHAN

P

1128J

Tablet 2mg

—

—

482

41,061

NITROSOUREAS

L01AD05

FOTEMUSTINE

P

5900M

Powder for injection 208mg with solvent

—

—

397

407,793

P

8786K

Powder for injection 208mg with solvent

—

—

697

995,703

OTHER ALKYLATING AGENTS

L01AX03

TEMOZOLOMIDE

P

8378Y

Capsule 5mg

—

—

289

79,652

P

8379B

Capsule 20mg 5

—

—

1,292

849,175

P

8380C

Capsule 100mg 5

—

—

4,698

11,437,106

P

8381D

Capsule 250mg 5

—

—

1,483

2,838,972

P

8819E

Capsule 5mg 15

—

—

386

131,428

P

8820F

Capsule 20mg 15

—

—

423

287,269

P

8821G

Capsule 100mg 15

—

—

539

1,375,070

P

9361Q

Capsule 140mg 15

—

—

1,131

4,033,033

P

9362R

Capsule 140mg 5

—

—

1,391

3,393,276

ANTIMETABOLITES

FOLIC ACID ANALOGUES

L01BA01

METHOTREXATE

P

1622J

Tablet 2.5mg

—

—

66,905

887,923

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
ANTIMETABOLITES

P

1623K

Tablet 10mg

—

—

111,764

5,128,258

P

2272N

Tablet 10mg 15

—

—

24,859

551,852

P

2395C

Injection 50mg in 2mL

—

—

17,464

633,552

P

2396D

Injection 5mg in 2mL

—

—

1,729

126,315

P

5875F

Solution concentrate I.V. infusion 1000mg in 10mL

—

—

294

28,525

P

5962T

Injection 5mg in 2mL

—

—

927

15,050

P

5963W

Injection 50mg in 2mL

—

—

424

6,938

P

8851W

Solution concentrate I.V. infusion 1000mg in 10mL

—

—

388

80,657

P

8852X

Solution concentrate I.V. infusion 5000mg in 50mL

—

—

273

191,650

P

8863L

Solution concentrate I.V. infusion 500mg in 20mL

—

—

114

7,676

L01BA04

PEMETREXED

P

5834C

Powder for I.V. infusion 500mg (base) 2

—

—

3,161

4,996,232

P

5835D

Powder for I.V. infusion 100mg (base) 1

—

—

1,742

1,117,477

P

9130M

Powder for I.V. infusion 500mg (base) 2

—

—

4,690

8,567,080

P

9131N

Powder for I.V. infusion 100mg (base) 1

—

—

5,531

11,007,713

L01BA03

RALTITREXED

P

8284B

Powder for I.V. infusion 2mg

—

—

219

191,545

PURINE ANALOGUES

L01BB05

FLUDARABINE

P

5840J

Powder for I.V. injection 50mg 5

—

—

394

252,954

P

5841K

Solution for I.V. injection 50mg in 2mL 5

—

—

217

102,422

P

9184J

Tablet 10mg 20

—

—

845

884,616

P

9185K

Powder for I.V. injection 50mg 5

—

—

591

794,111

P

9207N

Solution for I.V. injection 50mg in 2mL 5

—

—

191

252,445

L01BB02

MERCAPTOPURINE

P

1598D

Tablet 50mg

—

—

18,164

4,465,835

L01BB03

THIOGUANINE

P

1233X

Tablet 40mg

—

—

745

192,058

PYRIMIDINE ANALOGUES

L01BC06

CAPECITABINE

P

8361C

Tablet 150mg

—

—

1,578

207,826

P

8362D

Tablet 500mg 120

—

—

23,609

17,285,913

L01BC01

CYTARABINE

P

2884T

Injection set containing 100mg and 5mL solvent

—

—

1,460

775,111

P

5918L

Injection set containing 100mg and 5mL solvent

—

—

823

37,083

L01BC02

FLUOROURACIL

P

2528C

Injection 500mg in 10mL

—

—

41,099

2,265,477

P

4222F

Cream 50mg per g (5%) 20g

—

—

99,140

5,349,903

P

5872C

Injection 1000mg in 20mL 5

—

—

9,643

259,743

P

5935J

Injection 500mg in 10mL

—

—

13,355

394,758

P

9005Y

Injection 1000mg in 20mL 5

—

—

11,818

601,538

L01BC05

GEMCITABINE

P

5843M

Solution concentrate for I.V. infusion 200mg (base) in 20mL

—

—

186

27,154

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
ANTIMETABOLITES

P

5844N

Solution concentrate for I.V. infusion 1000mg (base) in 100mL

—

—

692

223,733

P

5845P

Solution concentrate for I.V. infusion 2gm (base)

—

—

968

423,158

P

5852B

Solution concentrate for I.V. infusion 500mg (base) in 50mL 4

—

—

204

33,774

P

5936K

Powder for I.V. infusion 200mg (base)

—

—

4,077

533,214

P

5937L

Powder for I.V. infusion 1gm (base)

—

—

6,806

2,279,802

P

8049P

Powder for I.V. infusion 200mg (base)

—

—

5,053

2,111,132

P

8050Q

Powder for I.V. infusion 1gm (base)

—

—

11,741

9,167,926

P

9401T

Solution concentrate for I.V. infusion 200mg (base) in 20mL

—

—

947

599,863

P

9402W

Solution concentrate for I.V. infusion 1000mg (base) in 100mL

—

—

1,260

1,064,379

P

9414L

Solution concentrate for I.V. infusion 2gm (base)

—

—

2,018

2,285,750

P

9463C

Solution concentrate for I.V. infusion 500mg (base) in 50mL 4

—

—

671

384,919

PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS

VINCA ALKALOIDS AND ANALOGUES

L01CA01

VINBLASTINE SULPHATE

P

2199R

Injection set containing 10mg and 10mL solvent

—

—

1,319

140,859

P

5989F

Injection set containing 10mg and 10mL solvent

—

—

1,266

44,560

L01CA02

VINCRISTINE SULPHATE

P

2374Y

Injection set containing 1mg and 1mL solvent

—

—

5,309

653,276

P

5991H

Injection set containing 1mg and 1mL solvent

—

—

4,350

118,918

L01CA04

VINORELBINE

P

5992J

Solution for I.V. infusion 10mg (base) in 1mL

—

—

364

86,453

P

5993K

Solution for I.V. infusion 50mg (base) in 5mL

—

—

1,387

462,748

P

8280T

Solution for I.V. infusion 10mg (base) in 1mL

—

—

624

620,460

P

8281W

Solution for I.V. infusion 50mg (base) in 5mL

—

—

1,426

1,291,939

P

9009E

Capsule 20mg (base) 20

—

—

124

198,476

PODOPHYLLOTOXIN DERIVATIVES

L01CB01

ETOPOSIDE

P

1389D

Capsule 100mg

—

—

474

166,355

P

1390E

Solution for I.V. infusion 100mg in 5mL

—

—

3,266

537,302

P

1396L

Capsule 50mg

—

—

620

251,867

P

5931E

Solution for I.V. infusion 100mg in 5mL

—

—

852

76,743

P

5932F

Powder for I.V. infusion 100mg (as phosphate)

—

—

4,605

350,864

P

5933G

Powder for I.V. infusion 1g (as phosphate)

—

—

223

60,923

P

8120J

Powder for I.V. infusion 100mg (as phosphate)

—

—

3,174

502,651

P

8515E

Powder for I.V. infusion 1g (as phosphate)

—

—

1,912

631,544

P

9010F

Capsule 30mg,16

—

—

258

490,028

TAXANES

L01CD02

DOCETAXEL

P

5921P

Injection set containing I.V. infusion 20mg

—

—

4,272

2,534,427

P

5922Q

Injection set containing I.V. infusion 80mg

—

—

6,580

9,344,541

P

8071T

Injection set containing I.V. infusion 20mg

—

—

10,678

16,645,066

P

8074Y

Injection set containing I.V. infusion 80mg

—

—

13,336

29,370,447

P

9291B

Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous)

—

—

405

687,632

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS

L01CD01

PACLITAXEL

P

3017T

Solution for I.V. infusion 150mg in 25mL

—

—

5,193

11,113,051

P

3026G

Solution for I.V. infusion 30mg in 5mL

—

—

5,937

7,415,081

P

5847R

Solution for I.V. infusion 100mg (base) 1

—

—

4,667

3,027,962

P

5973J

Solution for I.V. infusion 30mg in 5mL

—

—

2,294

813,610

P

5974K

Solution for I.V. infusion 100mg in 16.7mL

—

—

1,928

1,451,908

P

5975L

Solution for I.V. infusion 150mg in 25mL

—

—

1,931

1,912,377

P

5976M

Solution for I.V. infusion 300mg in 50mL

—

—

1,544

2,612,863

P

8018B

Solution for I.V. infusion 100mg in 16.7mL

—

—

3,770

6,757,522

P

8360B

Solution for I.V. infusion 300mg in 50mL

—

—

3,633

7,393,627

P

9415M

Solution for I.V. infusion 100mg (base) 1

—

—

5,432

10,319,829

CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES

ANTHRACYCLINES AND RELATED SUBSTANCES

L01DB01

DOXORUBICIN HYDROCHLORIDE

P

1336H

Solution for I.V. or intravesical 10mg

—

—

694

25,674

P

1340M

Solution for I.V. or intravesical 20mg

—

—

549

46,911

P

1342P

Solution for I.V. or intravesical 50mg

—

—

8,595

1,090,952

P

5879K

Solution for I.V. or intravesical 100mg in 50mL

—

—

3,069

348,070

P

5880L

Solution for I.V. or intravesical 200mg in 100mL

—

—

383

55,982

P

5891C

Solution for I.V. infusion 20mg in 10mL

—

—

908

839,168

P

5892D

Suspn for IV infusion 50mg in 25mL

—

—

688

1,070,943

P

5925W

Solution for I.V. or intravesical 10mg

—

—

580

10,371

P

5926X

Solution for I.V. or intravesical 20mg

—

—

1,036

37,931

P

5927Y

Solution for I.V. or intravesical 50mg

—

—

3,668

226,118

P

8569B

Suspn for IV infusion 20mg in 10mL

—

—

2,091

4,074,069

P

8570C

Suspn for IV infusion 50mg in 25mL

—

—

1,631

3,411,950

P

8827N

Solution for I.V. or intravesical 100mg in 50mL

—

—

6,458

946,706

P

8828P

Solution for I.V. or intravesical 200mg in 100mL

—

—

513

94,845

L01DB03

EPIRUBICIN HYDROCHLORIDE

P

1375J

Solution for I.V. injection 10mg in 5mL 4

—

—

389

61,144

P

1376K

Solution for I.V. injection 20mg in 10mL 4

—

—

183

75,960

P

1377L

Solution for I.V. injection 50mg in 25mL 3

—

—

5,263

4,612,981

P

5884Q

Solution for injection 200mg in 100mL

—

—

840

686,854

P

5885R

Solution for injection 100mg in 50mL 2

—

—

1,612

926,886

P

5928B

Solution for I.V. injection 10mg in 5mL 4

—

—

442

37,562

P

5929C

Solution for I.V. injection 20mg in 10mL 4

—

—

440

76,963

P

5930D

Solution for I.V. injection 50mg in 25mL 3

—

—

1,689

890,516

P

8817C

Solution for injection 100mg in 50mL 2

—

—

2,643

2,220,622

P

8858F

Solution for injection 200mg in 100mL

—

—

1,349

1,301,215

L01DB06

IDARUBICIN HYDROCHLORIDE

P

8531B

Solution for I.V. injection 10mg in 10mL

—

—

165

327,653

L01DB07

MITOZANTRONE

P

1929M

Injection 20mg in 10mL

—

—

1,082

215,272

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES

P

1930N

Injection 25mg in 12.5mL

—

—

757

180,448

P

1932Q

Injection 10mg in 5mL

—

—

175

17,564

P

5965Y

Injection 20mg in 10mL

—

—

284

45,642

P

5966B

Injection 25mg in 12.5mL

—

—

179

36,128

OTHER CYTOTOXIC ANTIBIOTICS

L01DC01

BLEOMYCIN

P

2315W

Injection 15,000 units (solvent required)

—

—

1,144

387,343

P

5903Q

Injection 15,000 units (solvent required)

—

—

1,981

169,664

P

6896Y

Injection 15,000 units 10mL and NS

—

—

127

32,969

OTHER ANTINEOPLASTIC AGENTS

PLATINUM COMPOUNDS

L01XA02

CARBOPLATIN

P

1160C

Solution for I.V. injection 50mg in 5mL

—

—

1,933

110,378

P

1161D

Solution for I.V. injection 150mg in 15mL

—

—

14,756

5,456,397

P

1162E

Solution for I.V. injection 450mg in 45mL

—

—

8,068

1,952,583

P

5906W

Solution for I.V. injection 50mg in 5mL

—

—

2,498

94,920

P

5907X

Solution for I.V. injection 150mg in 15mL

—

—

6,582

980,926

P

5908Y

Solution for I.V. injection 450mg in 45mL

—

—

6,054

869,712

L01XA01

CISPLATIN

P

2578Q

I.V. injection 10mg in 10mL

—

—

184

3,537

P

2579R

I.V. injection 50mg in 50mL

—

—

4,634

196,581

P

2580T

I.V. injection 100mg in 100mL

—

—

11,315

722,815

P

5909B

I.V. injection 10mg in 10mL

—

—

341

2,260

P

5910C

I.V. injection 50mg in 50mL

—

—

2,076

37,046

P

5911D

I.V. injection 100mg in 100mL

—

—

5,884

264,020

L01XA03

OXALIPLATIN

P

2310N

Powder for I.V. infusion 200mg in 40mL

—

—

3,284

6,267,753

P

5877H

Solution for I.V. infusion 50mg in 10mL

—

—

1,900

719,454

P

5878J

Solution for I.V. infusion 100mg in 20mL

—

—

3,148

2,605,729

P

5994L

Powder for I.V. infusion 50mg

—

—

1,397

506,444

P

5995M

Powder for I.V. infusion 100mg

—

—

2,429

2,111,026

P

5999R

Powder for I.V. infusion 200mg in 40mL

—

—

1,740

2,116,229

P

8539K

Powder for I.V. infusion 50mg

—

—

6,245

6,865,600

P

8540L

Powder for I.V. infusion 100mg

—

—

6,688

11,456,664

P

8847P

Solution for I.V. infusion 50mg in 10mL

—

—

2,084

2,587,209

P

8848Q

Solution for I.V. infusion 100mg in 20mL

—

—

2,680

4,760,730

MONOCLONAL ANTIBODIES

L01XC07

BEVACIZUMAB

P

5849W

Soln for IV infusion 100mg/4mL

—

—

3,799

2,252,408

P

5850X

Soln for IV infusion 400mg/16mL

—

—

4,645

8,627,520

P

9442Y

Soln for IV infusion 100mg/4mL

—

—

8,942

14,856,435

P

9443B

Soln for IV infusion 400mg/16mL

—

—

11,614

30,046,030

L01XC06

CETUXIMAB

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS

P

5836E

Solution for IV infusion 100mg in 20mL 1

—

—

265

101,618

P

5837F

Solution for IV infusion 500mg in 100mL 1

—

—

207

358,050

P

5838G

Solution for IV infusion 100mg in 20mL 1

—

—

142

85,250

P

5839H

Solution for IV infusion 500mg in 100mL 1

—

—

210

358,050

P

9138Y

Solution for IV infusion 100mg in 20mL 1

—

—

189

313,156

P

9139B

Solution for IV infusion 500mg in 100mL 1

—

—

225

499,287

L01XC02

RITUXIMAB

P

5896H

Solution for IV infusion 100mg\10mL

—

—

4,837

3,731,738

P

5897J

Solution for IV infusion 500mg\50mL

—

—

4,119

9,368,916

P

5978P

Solution for IV infusion 100mg\10mL

—

—

5,115

4,143,257

P

5979Q

Solution for IV infusion 500mg\50mL

—

—

4,497

10,269,817

P

8293L

Solution for IV infusion 100mg\10mL

—

—

12,594

16,149,208

P

8294M

Solution for IV infusion 500mg\50mL

—

—

12,825

32,334,780

P

8665C

Solution for IV infusion 100mg\10mL

—

—

10,842

13,880,404

P

8666D

Solution for IV infusion 500mg\50mL

—

—

10,589

26,115,179

P

9611W

Solution for IV infusion 500mg\50mL

—

—

1,328

6,060,981

L01XC03

TRASTUZUMAB

P

6497Y

Powder for IV infusion 150mg

—

—

19,610

70,812,295

PROTEIN KINASE INHIBITORS

L01XE06

DASATINIB

P

2482P

Tablet 50mg 60

—

—

653

3,465,674

P

2485T

Tablet 70mg 60

—

—

211

1,349,441

P

9283N

Tablet 50mg 60

—

—

292

1,542,170

P

9341P

Tablet 100mg 60

—

—

111

584,691

L01XE03

ERLOTINIB

P

9166K

Tablet 25mg (as hydrochloride) 30

—

—

341

494,412

P

9167L

Tablet 100mg (as hydrochloride) 30

—

—

1,206

3,291,521

P

9168M

Tablet 150mg (as hydrochloride) 30

—

—

4,257

14,264,582

L01XE02

GEFITINIB

P

8769M

Tablet 250mg 30

—

—

347

1,350,057

L01XE01

IMATINIB

P

9111M

Tablet 100mg (base) 60

—

—

647

2,017,158

P

9112N

Tablet 400mg (base) 30

—

—

2,672

10,760,893

P

9113P

Tablet 100mg (base) 60

—

—

5,095

19,542,471

P

9114Q

Tablet 400mg (base) 30

—

—

12,435

52,620,710

P

9115R

Tablet 100mg (base) 60

—

—

497

2,244,185

P

9116T

Tablet 400mg (base) 30

—

—

719

3,540,385

P

9123E

Tablet 100mg (base) 60

—

—

235

782,741

P

9124F

Tablet 400mg (base) 30

—

—

207

827,889

P

9177B

Tablet 400mg (base) 30

—

—

171

669,593

L01XE07

LAPATINIB

P

9148L

Tablet 250mg 140

—

—

1,141

3,838,656

L01XE08

NILOTINIB

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS

P

9171Q

Capsule 200mg (as hydrochloride monohydrate) 112

—

—

734

4,069,794

P

9285Q

Capsule 200mg (as hydrochloride monohydrate) 112

—

—

372

2,048,187

L01XE05

SORAFENIB

P

9380Q

Tablet 200mg (as tosylate) 120

—

—

1,255

8,078,581

L01XE04

SUNITINIB

P

9417P

Capsule 12.5mg (as malate) 28

—

—

174

322,372

P

9418Q

Capsule 25mg (as malate) 28

—

—

284

1,010,202

P

9419R

Capsule 50mg (as malate) 28

—

—

538

3,779,018

P

9420T

Capsule 12.5mg (as malate) 28

—

—

1,343

2,682,542

P

9421W

Capsule 25mg (as malate) 28

—

—

2,075

7,395,731

P

9422X

Capsule 50mg (as malate) 28

—

—

980

6,824,500

P

9489K

Capsule 25mg (as malate) 28

—

—

146

515,160

P

9490L

Capsule 50mg (as malate) 28

—

—

139

980,453

OTHER ANTINEOPLASTIC AGENTS

L01XX27

ARSENIC TRIOXIDE

P

5851Y

Injection concentrate 10mg in 10mL 60

—

—

267

219,253

L01XX32

BORTEZOMIB

P

9117W

Powder for injection 3.5mg (solvent required) 4

—

—

1,775

12,763,879

P

9118X

Powder for injection 3.5mg (solvent required) 4

—

—

110

784,416

L01XX05

HYDROXYUREA

P

3093T

Capsule 500mg

—

—

35,565

2,741,700

L01XX19

IRINOTECAN

P

5833B

I V injection 500mg in 25mL

—

—

780

1,137,566

P

5846Q

I V injection 300mg in 15mL

—

—

851

884,126

P

5958N

I V injection 40mg in 2mL

—

—

1,941

283,599

P

5959P

I V injection 100mg in 5mL

—

—

3,784

2,258,288

P

8414W

I V injection 40mg in 2mL

—

—

2,357

1,343,856

P

8415X

I V injection 100mg in 5mL

—

—

5,378

6,699,301

P

9119Y

I V injection 500mg in 25mL

—

—

1,165

2,099,539

P

9410G

I V injection 300mg in 15mL

—

—

4,091

4,679,665

L01XX17

TOPOTECAN

P

5985B

Powder for I.V. infusion 4mg (base)

—

—

126

105,732

P

8199M

Powder for I.V. infusion 4mg (base)

—

—

260

504,201

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ENDOCRINE THERAPY
HORMONES AND RELATED AGENTS
PROGESTOGENS

L02AB02

MEDROXYPROGESTERONE

P

2316X

Tablet 200mg

1000.00

MG

1,487

155,067

P

2725K

Tablet 100mg

1000.00

MG

1,940

179,555

P

2727M

Tablet 250mg

1000.00

MG

195

25,214

P

2728N

Tablet 500mg

1000.00

MG

686

88,616

L02AB01

MEGESTROL

P

2734X

Tablet 160mg

160.00

MG

1,407

109,593

GONADOTROPHIN RELEASING HORMONE ANALOGUES

L02AE03

GOSERELIN

P

1454M

Subcutaneous implant 3.6mg

0.13

MG

20,621

6,854,976

P

8093Y

Subcutaneous implant 10.8mg (base) in prefilled injection syringe

0.13

MG

46,808

51,892,030

P

9064C

Subcutaneous implant 3.6mg (base) in prefilled injection syringe and 28 tabs 50mg

0.13

MG

413

199,157

P

9065D

Subcutaneous implant 10.8mg (base) in prefilled injection syringe and 28 tabs 50mg

0.13

MG

671

839,912

P

9066E

Subcutaneous implant 10.8mg (base) in prefilled injection syringe and 84 tabs 50mg

0.13

MG

3,106

4,785,308

L02AE02

LEUPRORELIN ACETATE

A

14727

Injection 5mg

0.13

MG

228

—

P

8707G

Suspn subcutaneous inj (mod rel) 7.5mg inj set

0.13

MG

829

348,113

P

8708H

Suspn subcutaneous inj (mod rel) 22.5mg inj set

0.13

MG

4,366

4,839,221

P

8709J

Suspn subcutaneous inj (mod rel) 30mg inj set

0.13

MG

1,058

1,535,748

P

8859G

Suspn subcutaneous inj (mod rel) 45mg inj set

0.13

MG

3,374

7,181,313

P

8875D

I.M. injection (modified release) 7.5mg diluent

0.13

MG

3,419

1,436,338

P

8876E

I.M. injection (modified release) 22.5mg diluent

0.13

MG

13,338

14,786,161

P

8877F

I.M. injection (modified release) 30mg diluent

0.13

MG

9,340

13,557,874

HORMONE ANTAGONISTS AND RELATED AGENTS

ANTI-ESTROGENS

L02BA01

TAMOXIFEN

P

2109B

Tablet 10mg (base) 60

20.00

MG

2,300

89,041

P

2110C

Tablet 20mg (base) 60

20.00

MG

120,076

7,189,988

L02BA02

TOREMIFENE

P

8216K

Tablet 60mg (base)

60.00

MG

1,677

118,984

ANTI-ANDROGENS

L02BB03

BICALUTAMIDE

P

8094B

Tablet 50mg

50.00

MG

36,535

6,244,366

L02BB01

FLUTAMIDE

P

1417N

Tablet 250mg

750.00

MG

2,393

496,602

L02BB02

NILUTAMIDE

P

8131Y

Tablet 150mg

30.00

MG

4,774

1,147,270

ENZYME INHIBITORS

L02BG03

ANASTROZOLE

P

8179L

Tablet 1mg

1.00

MG

215,977

38,882,707

L02BG06

EXEMESTANE

P

8506Q

Tablet 25mg 30

25.00

MG

22,525

4,053,798

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ENDOCRINE THERAPY
HORMONE ANTAGONISTS AND RELATED AGENTS

L02BG04

LETROZOLE

P

8245Y

Tablet 2.5mg

2.50

MG

127,812

23,009,391

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSTIMULANTS
CYTOKINES AND IMMUNOMODULATORS
COLONY STIMULATING FACTORS

L03AA02

FILGRASTIM

P

6126K

Injection 300ug in 1mL 20

0.35

MG

176

323,325

P

6291D

Injection 300ug in 0.5mL 20

0.35

MG

1,988

3,910,656

P

6292E

Injection 480ug in 0.5mL 20

0.35

MG

936

4,000,422

L03AA13

PEGFILGRASTIM

P

6363X

Injection 6mg in 0.6mL single use syringe

0.30

MG

15,884

33,300,663

INTERFERONS

L03AB07

INTERFERON BETA-1a

P

8289G

Inj. set 1 vial powder dose 30ug (6,000,000iu)

4.30

UG

2,533

2,671,012

P

8403G

Injection 44ug (12,000,000iu) in 0.5mL single syringe

4.30

UG

17,009

17,964,547

P

8805K

Injection 30ug (6,000,000iu) in 0.5mL single syringe

4.30

UG

19,410

20,514,049

P

9332E

Solution for injection 132ug in 1.5mL multidose cartridge 4

4.30

UG

2,234

2,478,364

L03AB08

INTERFERON BETA-1b

P

8101J

Injection set 1 vial powder dose 8,000,000iu

4.00

ME

32,332

38,145,142

L03AB04

INTERFERON-ALFA-2a

P

8180M

Solution for injection 3,000,000iu in 0.5mL 15

2.00

ME

1,353

745,476

P

8181N

Solution for injection 3,000,000iu in 0.5mL 15

2.00

ME

221

129,354

P

8551C

Injection 45,000,000iu in 0.5mL syringe 5

2.00

ME

132

73,081

L03AB05

INTERFERON-ALFA-2b

P

8348J

Solution for injection 18,000,000iu in 1.2mL multi-dose pen 3

2.00

ME

341

207,707

L03AB11

PEGINTERFERON ALFA-2a

P

6449K

Prefilled syringe 180ug/0.5mL 8

26.00

UG

301

446,671

L03AB61

RIBAVIRIN and PEGINTERFERON ALFA-2a

P

6394M

112 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2

—

—

407

697,041

P

6395N

140 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2

—

—

837

1,512,919

P

6396P

168 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2

—

—

1,156

2,236,288

L03AB60

RIBAVIRIN and PEGINTERFERON ALFA-2b

P

6405D

112 ribavirin 200mg/4 single use injection pens 2

—

—

325

536,062

P

6407F

140 ribavirin 200mg/4 single use injection pens 2

—

—

504

901,473

P

6410J

168 ribavirin 200mg/4 single use injection pens 2

—

—

204

504,511

OTHER IMMUNOSTIMULANTS

L03AX03

BCG VACCINE

P

1131M

Vial powder for intravesical admin. 5x10^8 CFU

—

—

1,620

886,414

P

1140B

Injection set 1 vial Powder

—

—

1,551

577,089

P

5901N

Injection set 1 vial Powder

—

—

789

173,610

P

5902P

Ampoule containing powder 5x10^8 CFU

—

—

217

49,674

L03AX13

GLATIRAMER ACETATE

P

8726G

Inj 20mg in 1mL single dose prefilled syringe

20.00

MG

25,194

27,524,049

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS
SELECTIVE IMMUNOSUPPRESSANTS

L04AA24

ABATACEPT

P

9621J

Powder for I.V. infusion 250mg

27.00

MG

6,064

9,567,624

L04AA18

EVEROLIMUS

P

8840G

Tablet 0.25mg 60

1.50

MG

215

65,647

P

8841H

Tablet 0.5mg 60

1.50

MG

687

501,188

P

8842J

Tablet 0.75mg 120

1.50

MG

411

679,874

L04AA13

LEFLUNOMIDE

P

8374R

Tablet 10mg 30

20.00

MG

53,186

4,977,981

P

8375T

Tablet 20mg 30

20.00

MG

127,068

17,597,031

L04AA06

MYCOPHENOLIC ACID

P

6208R

Capsule 250mg 600

2.00

GM

263

90,894

P

6209T

Tablet 500mg 300

2.00

GM

1,367

915,180

P

6370G

Tablet (enteric coated) 360mg 240

2.00

GM

234

136,739

P

8649F

Capsule 250mg 300

2.00

GM

1,560

919,955

P

8650G

Capsule 500mg 150

2.00

GM

9,195

5,871,181

P

8652J

Tablet (enteric coated) 180mg 120

2.00

GM

315

86,102

P

8653K

Tablet (enteric coated) 360mg 120

2.00

GM

1,496

751,655

L04AA23

NATALIZUMAB

P

9624M

Sol.concentrate for I.V. infusion 300mg in 15mL

10.00

MG

3,948

8,278,918

L04AA10

SIROLIMUS

P

8724E

Tablet 1mg 100

3.00

MG

470

400,418

P

8833X

Tablet 2mg 100

3.00

MG

233

385,362

TUMOR NECROSIS FACTOR ALPHA INHIBITORS

L04AB04

ADALIMUMAB

P

8737W

Injection 40mg in 0.8mL prefilled syringe

2.90

MG

1,128

1,997,650

P

8741C

Injection 40mg in 0.8mL prefilled syringe

2.90

MG

12,788

22,682,273

P

9033K

Injection 40mg in 0.8mL prefilled syringe

2.90

MG

282

500,028

P

9034L

Injection 40mg in 0.8mL prefilled syringe

2.90

MG

2,444

4,334,653

P

9077R

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

348

616,245

P

9078T

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

2,484

4,403,939

P

9099X

Injection 40mg in 0.8mL prefilled syringe

2.90

MG

4,147

7,350,011

P

9100Y

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

27,381

48,571,780

P

9101B

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

1,526

2,707,783

P

9102C

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

7,807

13,850,045

P

9103D

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

1,553

2,751,172

P

9104E

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

8,773

15,556,186

P

9186L

Injection 40mg in 0.8mL prefilled syringe 6

2.90

MG

173

905,161

P

9187M

Injection 40mg in 0.8mL prefilled pen 6

2.90

MG

488

2,482,802

P

9188N

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

561

995,960

P

9189P

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

3,591

6,369,935

P

9190Q

Injection 40mg in 0.8mL prefilled pen 2

2.90

MG

1,454

2,583,075

P

9191R

Injection 40mg in 0.8mL prefilled pen 2

2.90

MG

8,040

14,272,072

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS

P

9425C

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

869

1,538,663

P

9426D

Injection 40mg in 0.8mL prefilled pen 2

2.90

MG

1,023

1,813,353

P

9427E

Injection 40mg in 0.8mL prefilled syringe 2

2.90

MG

3,044

5,398,488

P

9428F

Injection 40mg in 0.8mL prefilled pen 2

2.90

MG

3,440

6,104,097

L04AB05

CERTOLIZUMAB PEGOL

P

3425G

Injection 200mg in 1mL single use prefilled syringe 1

14.00

MG

371

634,546

L04AB01

ETANERCEPT

P

6367D

Injection set 4 vial pdr 25mg and 4 syringe solvent

7.00

MG

1,487

2,500,848

P

8637N

Injection set 4 vial pdr 25mg and 4 syringe solvent

7.00

MG

165

301,907

P

8638P

Injection set 4 vial pdr 25mg and 4 syringe solvent

7.00

MG

3,128

5,743,028

P

8779C

Injection set 4 vial pdr 25mg and 4 syringe solvent

7.00

MG

830

1,507,983

P

9036N

Injection set 4 vial pdr 25mg and 4 syringe solvent

7.00

MG

381

694,962

P

9085E

Injection 50mg in 1mL single use prefilled syr, 4

7.00

MG

706

1,251,353

P

9086F

Injection 50mg in 1mL single use prefilled syr, 4

7.00

MG

5,353

9,515,675

P

9087G

Injection 50mg in 1mL single use prefilled syr, 4

7.00

MG

279

495,050

P

9088H

Injection 50mg in 1mL single use prefilled syr, 4

7.00

MG

3,340

5,926,309

P

9089J

Injection 50mg in 1mL single use prefilled syr, 4

7.00

MG

1,137

2,022,801

P

9090K

Injection 50mg in 1mL single use prefilled syr, 4

7.00

MG

20,231

35,935,942

P

9091L

Injection 50mg in 1mL single use prefilled syr, 4

7.00

MG

212

381,471

P

9429G

Injection set 4 vial pdr 25mg and 4 syringe solvent

7.00

MG

171

305,437

P

9431J

Injection 50mg in 1mL single use prefilled syr, 4

7.00

MG

3,398

6,036,088

P

9455P

Injection 50mg in 1mL single use auto injector, 4

7.00

MG

713

1,270,449

P

9456Q

Injection 50mg in 1mL single use auto injector, 4

7.00

MG

3,815

6,811,875

P

9457R

Injection 50mg in 1mL single use auto injector, 4

7.00

MG

858

1,522,411

P

9458T

Injection 50mg in 1mL single use auto injector, 4

7.00

MG

2,922

5,184,977

P

9459W

Injection 50mg in 1mL single use auto injector, 4

7.00

MG

3,631

6,458,710

P

9460X

Injection 50mg in 1mL single use auto injector, 4

7.00

MG

15,530

27,582,094

P

9461Y

Injection 50mg in 1mL single use auto injector, 4

7.00

MG

217

385,185

P

9462B

Injection 50mg in 1mL single use auto injector, 4

7.00

MG

784

1,401,889

P

9615C

Injection 50mg in 1mL single use prefilled syr, 4

7.00

MG

310

521,292

P

9641K

Injection 50mg in 1mL single use auto injector, 4

7.00

MG

126

210,952

L04AB06

GOLIMUMAB

P

3426H

Injection 50mg in 0.5mL single use prefilled syringe 1

1.66

MG

260

462,095

P

3427J

Injection 50mg in 0.5mL single use prefilled pen 1

1.66

MG

960

1,706,216

P

3429L

Injection 50mg in 0.5mL single use prefilled pen 1

1.66

MG

545

967,572

P

3431N

Injection 50mg in 0.5mL single use prefilled pen 1

1.66

MG

346

614,979

P

3433Q

Injection 50mg in 0.5mL single use prefilled pen 1

1.66

MG

178

316,358

P

3434R

Injection 50mg in 0.5mL single use prefilled syringe 1

1.66

MG

116

206,146

P

3435T

Injection 50mg in 0.5mL single use prefilled pen 1

1.66

MG

451

801,649

P

3437X

Injection 50mg in 0.5mL single use prefilled pen 1

1.66

MG

218

387,449

L04AB02

INFLIXIMAB

P

6397Q

Powder for I.V. infusion 100mg 1

3.75

MG

1,515

3,534,623

P

6448J

Powder for I.V. infusion 100mg 1

3.75

MG

3,552

12,423,552

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS

P

6496X

Powder for I.V. infusion 100mg 1

3.75

MG

839

3,131,130

P

9612X

Powder for I.V. infusion 100mg 1

3.75

MG

441

1,117,610

P

9613Y

Powder for I.V. infusion 100mg 1

3.75

MG

3,968

12,639,373

P

9617E

Powder for I.V. infusion 100mg 1

3.75

MG

1,332

4,984,221

P

9674E

Powder for I.V. infusion 100mg 1

3.75

MG

127

417,275

INTERLEUKIN INHIBITORS

L04AC03

ANAKINRA

P

8774T

Injection 100mg in 0.67mL pre-filled syringe 28

0.10

GM

173

236,092

L04AC07

TOCILIZUMAB

P

9671B

Concentrate for injection 80mg in 4mL 1

20.00

MG

1,416

582,453

P

9672C

Concentrate for injection 200mg in 10mL 1

20.00

MG

669

392,521

P

9673D

Concentrate for injection 400mg in 20mL 1

20.00

MG

1,796

2,196,746

L04AC05

USTEKINUMAB

P

9304Q

Injection 45mg in 0.5mL

0.54

MG

1,081

6,969,368

P

9305R

Injection 45mg in 0.5mL

0.54

MG

263

1,789,144

CALCINEURIN INHIBITORS

L04AD01

CYCLOSPORIN

P

6232B

Capsule 10mg (with microemulsion pre-concentrate) 120

0.25

GM

327

27,558

P

6352H

Capsule 25mg 120

0.25

GM

1,130

217,405

P

6353J

Capsule 50mg 120

0.25

GM

1,476

382,554

P

6354K

Capsule 100mg 120

0.25

GM

1,693

865,750

P

8657P

Capsule 10mg 120

0.25

GM

1,209

132,737

P

8658Q

Capsule 25mg 60

0.25

GM

9,769

1,327,788

P

8659R

Capsule 50mg 60

0.25

GM

13,192

2,865,097

P

8660T

Capsule 100mg 60

0.25

GM

12,571

5,449,404

P

8661W

Oral liquid 100mg per mL

0.25

GM

336

212,627

L04AD02

TACROLIMUS

P

6216E

Capsule 1mg 200

5.00

MG

953

749,418

P

6328C

Capsule 500ug 200

5.00

MG

226

52,156

P

8646C

Capsule 500ug 100

5.00

MG

3,364

762,975

P

8647D

Capsule 1mg 100

5.00

MG

10,377

6,258,369

P

8648E

Capsule 5mg 100

5.00

MG

559

905,511

OTHER IMMUNOSUPPRESSANTS

L04AX01

AZATHIOPRINE

P

2687K

Tablet 50mg

0.15

GM

136,999

7,837,044

P

2688L

Tablet 25mg

0.15

GM

16,199

598,275

L04AX04

LENALIDOMIDE

P

9642L

Capsule 5mg 21

10.00

MG

184

1,015,391

P

9643M

Capsule 10mg 21

10.00

MG

542

3,176,251

P

9644N

Capsule 15mg 21

10.00

MG

757

4,970,586

P

9645P

Capsule 25mg 21

10.00

MG

1,812

12,612,259

L04AX02

THALIDOMIDE

P

6469L

Capsules 50mg 112

0.10

GM

3,328

3,606,640